DEA Acknowledges Cannabis Research Needs

DEA Proposes Surplus Production Quotas for Cannabinoids and Psychedelics to Support Research. The Drug Enforcement Administration (DEA) has proposed a considerable surplus to the originally-established 2023 production quotas of cannabinoids and psychedelics toward supporting preclinical and clinical